Search research articles
Contact Us
Filters
Showing results (201-210 of 259) with videos related to
Page
of 26
Sort By:
Organic & Biomolecular Chemistry
|
November 19, 2010
Computational and experimental investigations of mono-septanoside binding by Concanavalin A: correlation of ligand stereochemistry to enthalpies of binding
Michael R Duff, W Sean Fyvie, Shankar D Markad, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Characterization of immunotoxins active against ovarian cancer cell lines
R Pirker, D J FitzGerald, T C Hamilton, et al.
Clinical Breast Cancer
|
April 10, 2021
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy
Barbara Haley, Kiran Batra, Sunati Sahoo, et al.
Frontiers in Bioscience (Landmark Edition)
|
March 11, 2009
Pathophysiology of anthrax
Arthur E Frankel, Shu-Ru Kuo, David Dostal, et al.
Cancer Research
|
July 15, 1989
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate
L M Weiner, J O'Dwyer, J Kitson, et al.
Biochemistry
|
August 27, 1996
Structure and activity of an active site substitution of ricin A chain
P J Day, S R Ernst, A E Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice
Ralph J Abi-Habib, Ravibhushan Singh, Stephen H Leppla, et al.
Current Drug Targets
|
February 10, 2009
Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma
A E Frankel, S L Zuckero, A A Mankin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor
Philippe Depeille, John J Young, Elissa A Boguslawski, et al.
Journal of Immunological Methods
|
October 16, 1996
Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies
D A Vallera, L J Burns, A E Frankel, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 259) with videos related to
Sort By:
Page
of 26
Organic & Biomolecular Chemistry
|
November 19, 2010
Computational and experimental investigations of mono-septanoside binding by Concanavalin A: correlation of ligand stereochemistry to enthalpies of binding
Michael R Duff, W Sean Fyvie, Shankar D Markad, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Characterization of immunotoxins active against ovarian cancer cell lines
R Pirker, D J FitzGerald, T C Hamilton, et al.
Clinical Breast Cancer
|
April 10, 2021
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy
Barbara Haley, Kiran Batra, Sunati Sahoo, et al.
Frontiers in Bioscience (Landmark Edition)
|
March 11, 2009
Pathophysiology of anthrax
Arthur E Frankel, Shu-Ru Kuo, David Dostal, et al.
Cancer Research
|
July 15, 1989
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate
L M Weiner, J O'Dwyer, J Kitson, et al.
Biochemistry
|
August 27, 1996
Structure and activity of an active site substitution of ricin A chain
P J Day, S R Ernst, A E Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice
Ralph J Abi-Habib, Ravibhushan Singh, Stephen H Leppla, et al.
Current Drug Targets
|
February 10, 2009
Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma
A E Frankel, S L Zuckero, A A Mankin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor
Philippe Depeille, John J Young, Elissa A Boguslawski, et al.
Journal of Immunological Methods
|
October 16, 1996
Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies
D A Vallera, L J Burns, A E Frankel, et al.
Page
of 26